We're clinicians, technologists, patients, and researchers partnering to increase access to science-backed mental health treatments, starting with guided ketamine therapy for depression and anxiety.
Mental health is the #1 public health crisis. It has touched millions of Americans, including our founder, Dylan Beynon.
Dylan grew up in a family that was torn apart by mental illness. He lost both his mother and sister to severe mental illnesses, addiction, and eventually overdose. For years he struggled to process the impact these losses had on him.
It was not until 2009 that Dylan began the healing process when he discovered psychedelic medicines. Through his experiences with these medicines, he was able to build a healthier relationship with himself and those he loves.
In 2018, this journey led to ketamine therapy, a treatment that is still changing his life for the better. Since then, Dylan has dedicated his life to helping increase access to these transformational and safe new medicines.
Nothing is more central to leading a happy, fulfilling life than mental health.
At Mindbloom, we’re on a mission to transform lives to transform the world. New medicines have arrived that not only treat the symptoms of mental pain, but help us address their root causes.
Medicines shown by science to be not only safe, but effective. It’s a new day for mental health and the future looks bright.
Supported by Research
In the largest ketamine therapy study to date, 89% of clients reported improvement in their anxiety and depression symptoms after 4 sessions.
Experienced and Professional Team
Our program is prescribed by medically-licensed Clinicians to ensure you undergo treatment safely. Our team has safely completed over 300,000 sessions of ketamine therapy and are always available to offer support or answer questions.